Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
DU ›
DUFORZIG
Trademark search for:
DUFORZIG
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-02-22 — Application filed
2012-02-25 — Application filed
2012-02-29 — Application filed
2012-05-21 — Assigned to examiner
2012-05-25 — Final disposition recorded
2012-05-25 — Final disposition recorded
2012-05-25 — Final disposition recorded
2012-07-20 — Office action issued
2012-07-27 — Assigned to lie
2012-08-02 — Approved for pub - principal register
2012-08-02 — Teas/email correspondence entered
2012-08-02 — Correspondence received in law office
2012-08-03 — Law office publication review completed
2012-08-22 — Notification of notice of publication e-mailed
2012-09-11 — Published for opposition
2012-09-11 — Official gazette publication confirmation e-mailed
2012-11-06 — Noa e-mailed - sou required from applicant
2013-03-12 — Teas change of correspondence received
2013-05-06 — Sou teas extension received
2013-05-06 — Sou extension 1 filed
2013-05-31 — Case assigned to intent to use paralegal
2013-06-04 — Sou extension 1 granted
2013-06-05 — Notice of approval of extension request e-mailed
2013-10-14 — Sou teas extension received
2013-10-14 — Sou extension 2 filed
2013-10-22 — Sou extension 2 granted
2013-10-23 — Notice of approval of extension request e-mailed
2014-03-18 — Attorney/dom.rep.revoked and/or appointed
2014-03-18 — Teas revoke/app/change addr of atty/dom rep received
2014-03-19 — Automatic update of assignment of ownership
2014-04-03 — Sou teas extension received
2014-04-03 — Sou extension 3 filed
2014-04-10 — Sou extension 3 granted
2014-04-11 — Notice of approval of extension request e-mailed
2014-10-08 — Assignment of ownership not updated automatically
2014-10-09 — Teas petition to amend basis received
2014-10-23 — Assigned to petition staff
2014-10-28 — Petition to director - change basis - granted
2014-10-29 — Fax received
2014-11-06 — Sou teas extension received
2014-11-06 — Sou extension 4 filed
2014-11-19 — Attorney review/decision on amendment required
2014-12-04 — Noa cancelled; republication required
2014-12-04 — Notice of allowance cancelled
2014-12-04 — Sou extension 4 granted
2014-12-24 — Notification of notice of publication e-mailed
2015-01-13 — Published for opposition
2015-01-13 — Official gazette publication confirmation e-mailed
2015-03-31 — Registered-principal register
2020-03-31 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas change of owner address received
2021-07-22 — Teas change of correspondence received
2021-07-22 — Applicant/correspondence changes (non-responsive) entered
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2021-11-19 — Cancelled sec. 8 (6-yr)
2021-11-19 — Final status recorded
Owner Information
ASTRAZENECA AB
ASTRAZENECA AB
Bristol-Myers Squibb Company
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
